Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience

Autor: Ionescu, Filip, Ajayi, Eloho, Leach, Aamia, Alsina, Melissa, Bejanyan, Nelli, Castaneda, Omar, Elmariah, Hany, Freeman, Ciara, Hansen, Doris K, Jain, Michael D, Khimani, Farhad, Lazaryan, Aleksandr, Liu, Hien, Locke, Frederick L., Mishra, Asmita, Nieder, Dr. Michael L., Ochoa, Leonel, Perez, Lia Elena, Pidala, Joseph A., Quilitz, Rod, Klinkova, Olga V, Baluch, Aliyah, Nishihori, Taiga, Faramand, Rawan G

Publikováno v: Transplantation and Cellular Therapy; February 2023, Vol. 29 Issue: 2, Number 2 Supplement 1 pS330-S331, 2p

The Addition of Systemic Terbinafine to Antifungal Combination Therapy in the Treatment of Disseminated Drug-Resistant Mold Infections in a National Cancer Institute Comprehensive Cancer Center: A Six-Year Study.

Autor: Thomas DB Jr; Transplant and Oncology Infectious Diseases, Houston Lee Moffitt Cancer Center & Research Institute, Tampa, USA., Ajayi E; Infectious Diseases, Houston Lee Moffitt Cancer Center & Research Institute, Tampa, USA., Sikora A; Infectious Diseases and International Medicine, University of South Florida, Morsani College of Medicine, Tampa, USA., Cozzini L; Infectious Diseases, Houston Lee Moffitt Cancer Center & Research Institute, Tampa, USA., Quilitz R; Clinical Pharmacy, Houston Lee Moffitt Cancer Center & Research Institute, Tampa, USA., Pasikhova Y; Clinical Pharmacy, Moffitt Cancer Center, Tampa, USA., Klinkova O; Infectious Diseases, Moffitt Cancer Center, Tampa, USA., Baluch A; Infectious Diseases, Moffitt Cancer Center, Tampa, USA.

Publikováno v: Cureus [Cureus] 2024 Mar 01; Vol. 16 (3), pp. e55343. Date of Electronic Publication: 2024 Mar 01 (Print Publication: 2024).